Description |
mitogen-activated protein kinase 10 |
stathmin 2 |
Image |
|
No pdb structure |
Cellular Component |
|
|
Molecular Function |
|
|
Biological Process |
|
|
Pathways |
|
|
Drugs |
- Minocycline
- Pyrazolanthrone
- Cyclohexyl-{4-[5-(3,4-Dichlorophenyl)-2-Piperidin-4-Yl-3-Propyl-3h-Imidazol-4-Yl]-Pyrimidin-2-Yl}Amine
- Cyclopropyl-{4-[5-(3,4-Dichlorophenyl)-2-[(1-Methyl)-Piperidin]-4-Yl-3-Propyl-3h-Imidazol-4-Yl]-Pyrimidin-2-Yl}Amine
- 9-(4-Hydroxyphenyl)-2,7-Phenanthroline
- Phosphoaminophosphonic Acid-Adenylate Ester
- N-(tert-butyl)-4-[5-(pyridin-2-ylamino)quinolin-3-yl]benzenesulfonamide
- N-BENZYL-4-[4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL]-1H-PYRROLE-2-CARBOXAMIDE
- N-(3-cyano-4,5,6,7-tetrahydro-1-benzothien-2-yl)-2-fluorobenzamide
- 4-{[5-chloro-4-(1H-indol-3-yl)pyrimidin-2-yl]amino}-N-ethylpiperidine-1-carboxamide
- (3Z)-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-4-[(E)-2-phenylethenyl]-1H-indole-2,3-dione 3-oxime
- (3E)-5-fluoro-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-1H-indole-2,3-dione 3-oxime
- (3Z)-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-4-phenyl-1H-indole-2,3-dione 3-oxime
- 5-bromo-N-(3-chloro-2-(4-(prop-2-ynyl)piperazin-1-yl)phenyl)furan-2-carboxamide
- N-cyclohexyl-4-imidazo[1,2-a]pyridin-3-yl-N-methylpyrimidin-2-amine
- N-{2'-[(4-FLUOROPHENYL)AMINO]-4,4'-BIPYRIDIN-2-YL}-4-METHOXYCYCLOHEXANECARBOXAMIDE
- 2-{4-[(4-imidazo[1,2-a]pyridin-3-ylpyrimidin-2-yl)amino]piperidin-1-yl}-N-methylacetamide
- 1-(3-bromophenyl)-7-chloro-6-methoxy-3,4-dihydroisoquinoline
- Fostamatinib
- Halicin
|
|
Diseases |
|
|
GWAS |
- Cleft lip with or without cleft palate x maternal periconceptional smoking interaction (parent of origin effect) ( 31372216)
- Cobalt levels ( 26025379)
- Diisocyanate-induced asthma ( 25918132)
- Gait speed in old age ( 28077804)
- Liver enzyme levels (alanine transaminase) ( 22001757)
- Multiple sclerosis ( 31604244)
- Peripheral artery disease ( 25009551)
- Response to cytidine analogues (gemcitabine) ( 24483146)
- Triglyceride levels ( 32203549 32154731)
|
- Creutzfeldt-Jakob disease ( 19081515)
- Frontotemporal dementia with GRN mutation (age at onset) ( 29724592)
- Metabolite levels ( 23823483)
- Response to serotonin reuptake inhibitors in major depressive disorder ( 25897834)
|
Interacting Genes |
38 interacting genes:
APP
ARRB1
ARRB2
ATF2
BCL2L11
CDK5
CDKN1B
CDKN2A
CDKN2C
CEP290
CREBBP
DUSP10
DUSP16
DUSP9
ELK1
FBXO7
GTF3C1
HAX1
HDAC9
HNRNPK
HRAS
JUN
KIF26A
LDHA
MAP2K4
MAPK8IP2
MAPK8IP3
MAPKBP1
MAPT
MCL1
PKMYT1
PLIN2
RELA
SH3BP5
STMN2
TNIP1
TP53
UNC119
|
28 interacting genes:
CCDC85A
CCHCR1
CDC42
CDK1
CEP70
CTNNA3
EEF1A1
ERBB2
FAM90A1
FANCC
GPRASP1
GPRASP2
MAPK10
MAPK3
MBD3
NGFR
NTAQ1
PRKACA
PSMB1
PSMC1
RGS20
RGS6
SESTD1
TEX11
TFCP2
TRPC5
TXLNA
UBE2I
|
Entrez ID |
5602 |
11075 |
HPRD ID |
04207 |
09003 |
Ensembl ID |
ENSG00000109339
|
ENSG00000104435
|
Uniprot IDs |
A0A1P0B7D2
A0A286YEQ7
A0A286YES0
A0A286YF02
A0A286YF97
A0A286YFD7
A0A286YFN2
D6RCB1
D6RJF9
F8W9R5
I6L9F3
P53779
Q499Y8
|
Q93045
|
PDB IDs |
1JNK
1PMN
1PMU
1PMV
2B1P
2EXC
2O0U
2O2U
2OK1
2P33
2R9S
2WAJ
2ZDT
2ZDU
3CGF
3CGO
3DA6
3FI2
3FI3
3FV8
3G90
3G9L
3G9N
3KVX
3OXI
3OY1
3PTG
3RTP
3TTI
3TTJ
3V6R
3V6S
4H36
4H39
4H3B
4KKE
4KKG
4KKH
4U79
4W4V
4W4W
4W4X
4W4Y
4WHZ
4X21
4Y46
4Y5H
4Z9L
6EKD
6EMH
6EQ9
|
|
Enriched GO Terms of Interacting Partners? |
|
|
Tagcloud ? |
|
|
Tagcloud (Difference) ? |
|
|
Tagcloud (Intersection) ? |
|